ADAPTIVE BIOTECHNOLOGIES CORPORATION Expense Breakdown
No Expense Breakdown for ADPT on this site yet.
- 2026-06-30: MRD Business $2.41M; Immune Medicine Business $826.00K.
- 2025-06-30: MRD Business $2.46M; Immune Medicine Business $1.58M.
Source checked: the stored Expense Breakdown page for ADPT.
Expenses by product
Depreciation, Depletion and Amortization, Nonproduction: each quarter (3 month)
| Quarter end | MRD Business | Immune Medicine Business |
|---|
| 2026-06-30 | $2.41M | $826.00K |
|---|
| 2025-06-30 | $2.46M | $1.58M |
|---|
Research and development: each quarter (3 month)
| Quarter end | MRD Business | Immune Medicine Business |
|---|
| 2026-06-30 | $8.61M | $10.05M |
|---|
| 2025-06-30 | $8.50M | $15.05M |
|---|
Share-based Payment Arrangement, Expense: each quarter (3 month)
| Quarter end | MRD Business | Immune Medicine Business |
|---|
| 2026-06-30 | $6.25M | $2.96M |
|---|
| 2025-06-30 | $6.64M | $4.46M |
|---|
Cost of sales: each quarter (3 month)
| Quarter end | MRD Business |
|---|
| 2026-06-30 | $18.89M |
|---|
| 2025-06-30 | $16.54M |
|---|
General and Administrative Expense: each quarter (3 month)
| Quarter end | MRD Business |
|---|
| 2026-06-30 | $13.49M |
|---|
| 2025-06-30 | $10.13M |
|---|
Selling and Marketing Expense: each quarter (3 month)
| Quarter end | MRD Business |
|---|
| 2026-06-30 | $24.80M |
|---|
| 2025-06-30 | $21.95M |
|---|
Restructuring Charges: each quarter (3 month)
| Quarter end | MRD Business |
|---|
| 2026-06-30 | -$77.00K |
|---|